Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
202 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 52563 |
628 | 2 | SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR | 14172 |
7692 | 1 | METFORMIN//LACTIC ACIDOSIS//BIGUANIDES | 1363 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | METFORMIN | authKW | 2228450 | 46% | 15% | 627 |
2 | LACTIC ACIDOSIS | authKW | 579040 | 10% | 19% | 131 |
3 | BIGUANIDES | authKW | 288578 | 4% | 24% | 53 |
4 | METFORMIN ASSOCIATED LACTIC ACIDOSIS | authKW | 118909 | 0% | 86% | 6 |
5 | EXTENDED RELEASE METFORMIN | authKW | 69364 | 0% | 100% | 3 |
6 | METFORMIN ASSOCIATED LACTIC ACIDOSIS MALA | authKW | 69364 | 0% | 100% | 3 |
7 | METFORMIN INTOXICATION | authKW | 69364 | 0% | 100% | 3 |
8 | BOWEL UPTAKE | authKW | 61655 | 0% | 67% | 4 |
9 | NAZL INFORMAZ TOSSICOL | address | 52022 | 0% | 75% | 3 |
10 | ORAL ANTI DIABETIC THERAPY | authKW | 52022 | 0% | 75% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 12193 | 37% | 0% | 498 |
2 | Pharmacology & Pharmacy | 1930 | 24% | 0% | 321 |
3 | Medicine, General & Internal | 1432 | 16% | 0% | 220 |
4 | Primary Health Care | 183 | 1% | 0% | 17 |
5 | Urology & Nephrology | 130 | 4% | 0% | 49 |
6 | Toxicology | 120 | 4% | 0% | 49 |
7 | Medicine, Research & Experimental | 112 | 5% | 0% | 63 |
8 | Peripheral Vascular Diseases | 103 | 3% | 0% | 45 |
9 | Emergency Medicine | 54 | 1% | 0% | 14 |
10 | Cardiac & Cardiovascular System | 47 | 4% | 0% | 50 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NAZL INFORMAZ TOSSICOL | 52022 | 0% | 75% | 3 |
2 | INT PHARMACOL SUPPORT | 46243 | 0% | 100% | 2 |
3 | LYONNAISE IND PHARMACEUT | 46243 | 0% | 100% | 2 |
4 | METAB CLIN DESIGN EVALUAT | 46243 | 0% | 100% | 2 |
5 | UNIT MEDICAT OUTCOMES EDUCPHARM | 46243 | 0% | 100% | 2 |
6 | COMPARAT BIOCHEM PHYSIOL | 34679 | 0% | 50% | 3 |
7 | ABT ANASTHESIOL U INTENSIVMED | 23121 | 0% | 100% | 1 |
8 | ADULT ENDOCRINOL DIABET METAB | 23121 | 0% | 100% | 1 |
9 | ALMM VET HOSP | 23121 | 0% | 100% | 1 |
10 | ALTALANOS ORVOSTUD KAR OKTATO OSZTALYA | 23121 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DIABETES & METABOLISM | 43880 | 5% | 3% | 74 |
2 | DIABETES OBESITY & METABOLISM | 16579 | 3% | 2% | 41 |
3 | DIABETES-METABOLISM REVIEWS | 9033 | 1% | 4% | 11 |
4 | DIABETES CARE | 6445 | 4% | 0% | 57 |
5 | DIABETIC MEDICINE | 6313 | 3% | 1% | 40 |
6 | DIABETOLOGIA | 2402 | 2% | 0% | 30 |
7 | METABOLISM-CLINICAL AND EXPERIMENTAL | 1983 | 2% | 0% | 28 |
8 | LANCET DIABETES & ENDOCRINOLOGY | 1234 | 0% | 1% | 4 |
9 | DIABETES RESEARCH AND CLINICAL PRACTICE | 1189 | 1% | 0% | 17 |
10 | HORMONE AND METABOLIC RESEARCH | 1144 | 1% | 0% | 18 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |